Target Trial Emulation and Bias Through Missing Eligibility Data: An Application to a Study of Palivizumab for the Prevention of Hospitalization Due to Infant Respiratory Illness.
Target Trial Emulation and Bias Through Missing Eligibility Data: An Application to a Study of Palivizumab for the Prevention of Hospitalization Due to Infant Respiratory Illness.
复制标题
通过缺失资格数据的目标试验仿真和偏见:对帕利维珠单抗研究的应用,以预防婴儿呼吸道疾病引起的住院治疗。
DOI:
10.1093/aje/kwac202
复制
发表时间:
2023-04-06
影响因子:
5
通讯作者:
中科院分区:
文献类型:
--
作者:
Target trial emulation (TTE) applies the principles of randomized controlled trials to the causal analysis of observational data sets. One challenge that is rarely considered in TTE is the sources of bias that may arise if the variables involved in the definition of eligibility for the trial are missing. We highlight patterns of bias that might arise when estimating the causal effect of a point exposure when restricting the target trial to individuals with complete eligibility data. Simulations consider realistic scenarios where the variables affecting eligibility modify the causal effect of the exposure and are missing at random or missing not at random. We discuss means to address these patterns of bias, namely: 1) controlling for the collider bias induced by the missing data on eligibility, and 2) imputing the missing values of the eligibility variables prior to selection into the target trial. Results are compared with the results when TTE is performed ignoring the impact of missing eligibility. A study of palivizumab, a monoclonal antibody recommended for the prevention of respiratory hospital admissions due to respiratory syncytial virus in high-risk infants, is used for illustration.
登录
查看更多内容
影响因子:
2
作者:
Schomaker M;Heumann C
通讯作者:
Heumann C
影响因子:
1.9
作者:
Taylor, L.;Zhou, X. H.
通讯作者:
Zhou, X. H.
影响因子:
5
作者:
Hernan, Miguel A.;Robins, James M.
通讯作者:
Robins, James M.
影响因子:
5
作者:
Hong, Jin-Liern;Funk, Michele Jonsson;Sturmer, Til
通讯作者:
Sturmer, Til
影响因子:
2
作者:
Tompsett D;Sutton S;Seaman SR;White IR
通讯作者:
White IR